Answer
The mean half-life of lyophilised palivizumab was 20 days in prophylactic studies in premature children and children with bronchopulmonary dysplasia.
Sources for this answer
- Synagis 50 mg/0.5 ml solution for injectionAstraZeneca UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated
Sources checked